Tandem Nano Ltd Information

TNL uses its proprietary Soldi Drug Nanoparticle - SDN platform to potentially address problems of drug bioavailability and other poorly soluble compounds in a variety of industries including pharmaceuticals, agrochemicals and nutraceuticals. TNL has proprietary technology in Long Acting Injectables (LAI's) which have potentially huge impact on LMIC's and the developed world.